Woolcock Institute Of Medical Research
Clinical trials sponsored by Woolcock Institute Of Medical Research, explained in plain language.
-
Sleep pill may shield brain from damage in insomnia patients
Disease control Recruiting nowThis study tests whether a sleep drug (lemborexant) can lower levels of brain-damage-related proteins in the blood of adults with insomnia. Twenty participants aged 40–65 will take the drug or a placebo for two weeks each. The goal is to see if improving sleep can reduce markers …
Phase: PHASE2 • Sponsor: Woolcock Institute of Medical Research • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Online sleep therapy may ease anxiety, new study suggests
Symptom relief Recruiting nowThis study tests whether an online, therapist-guided therapy for chronic insomnia can also reduce anxiety symptoms and improve emotional health. About 98 adults with both insomnia and anxiety will be randomly assigned to start the therapy immediately or after a delay. Participant…
Phase: NA • Sponsor: Woolcock Institute of Medical Research • Aim: Symptom relief
Last updated May 20, 2026 12:08 UTC